SPLITOAK STRATEGIES LLC

Lobbying for CSL BEHRING LLC · Biotherapeutics company providing recombinant, plasma-derived and cell and gene products.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $40,000.00 income · posted Apr 20, 2026

Bills named in this filing 2

Lobbying activity 2

Health Issues

Issues related to plasma-derived therapies in rare diseases and critical care settings

Medicare/Medicaid

H.R.1476/S.694, PLASMA Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.